Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction

International Clinical Psychopharmacology

Volumn 12, Issue 1, 1997, Pages 61-63

  Spigset, O ^a   Adielsson, G ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Buspirone; Citalopram; Depression; Drug interaction; Hyponatraemia; Serotonin syndrome

Indexed keywords

BUSPIRONE; CITALOPRAM;

AGED; ARTICLE; CASE REPORT; DEPRESSION; DRUG INTERACTION; FEMALE; HUMAN; HYPONATREMIA; PRIORITY JOURNAL; SEROTONIN SYNDROME;

AGED; BUSPIRONE; CITALOPRAM; DEPRESSIVE DISORDER; DRUG INTERACTIONS; FEMALE; HUMANS; HYPONATREMIA; MENTAL DISORDERS; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0030899251     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199701000-00010     Document Type: Article

References (16)

1. Blier P, de Montigny C and Chaput Y (1990) A possible role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. Journal of Clinical Psychiatry, 51 (Suppl 4), 14-20.
2. Goldberg RJ and Huk M (1992) Serotonin syndrome from trazodone and buspirone. Psychosomatics, 33, 235-236.
3. 1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism. Psychopharmacology, 90, 488-493.
4. Joffe RJ and Schuller DR (1993) An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. Journal of Clinical Psychiatry, 54, 269-271.
5. Lejoyeux M, Adès J and Rouillon F (1994) Serotonin syndrome. CNS Drugs, 2, 132-143.
6. Lucki I, Nobler MS and Frazer A (1984) Differential actions of serotonin receptor activation on two behavioural syndromes of serotonin receptor activation in the rat. Journal of Pharmacology and Experimental Therapeutics, 228, 133-139.
7. Markowitz PJ, Stagno SJ and Calabrese JR (1990) Buspirone augmentation of fluvoxamine in obsessive-compulsive disorder. American Journal of Psychiatry, 147, 798-800.
8. Neuvonen PJ, Pohjola-Sintonen S, Tacke U, Vuori E (1993) Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine over-doses (Letter). Lancet, 342, 1419.
9. Power BM, Pinder M, Hackett LP, Ilett KF (1995) Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesthesia and Intensive Care, 23, 499-502.
10. Riblet LA and Taylor DP (1981) Pharmacology and neurochemistry of trazodone. Journal of Clinical Psychopharmacology, 1 (suppl 6), 17S-22S.
11. Sindrup SH, Brøsen K, Hansen MGJ, Aaes-Jørgensen, Overø KF, Gram LF (1993) Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms. Therapeutic Drug Monitoring, 15, 11-17.
12. Smith LM and Peroutka SJ (1986) Differential effects of 5-hydroxytryptamine-1A selective drugs on the 5-HT behavioral syndrome. Pharmacology, Biochemistry and Behavior, 24, 1513-1519.
13. Spigset O and Hedenmalm K (1995) Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Safety, 12, 209-225.
14. Sporer KA (1995) The serotonin syndrome. Drug Safety, 13, 94-104.
15. Sternbach H (1991) The serotonin syndrome. American Journal of Psychiatry, 148, 705-713.
16. 1A receptor in 5-HT syndrome induced in mice by tryptamine. Japanese Journal of Pharmacology, 51, 421-424.